CONNECT WITH US
HealthTech

HealthTech

COVID-19 pandemic disrupted cross-border fertility treatment in Czechia, new study finds

Medical Xpress logo

Published on

Add as a preferred source on Google
COVID-19 pandemic disrupted cross-border fertility treatment in Czechia, new study finds

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

The COVID-19 pandemic significantly disrupted access to fertility treatment for women traveling to Czechia from abroad, according to a new population-based study by researchers Anna Šťastná, Adéla Volejníková and Jiřina Kocourková from the Faculty of Science, Charles University. The findings reveal that international demand for assisted reproductive treatment declined substantially more than domestic demand, highlighting the vulnerability of patients who depend on cross-border reproductive health care.

The study, "Provision of cross-border reproductive care in Czechia during the COVID-19 pandemic: a population-based study," published in BMC Health Services Research, analyzed data from the Czech National Registry of Assisted Reproduction covering 231,363 assisted reproduction cycles initiated between 2016 and 2021, excluding egg donation. Of these, 93,834 cycles (41%) involved women traveling from abroad to undergo fertility treatment in Czechia.

The researchers found that while assisted reproduction cycles among women living in Czechia declined by just 2% during the pandemic, the number of cycles involving international patients fell by 27%.

This substantial difference demonstrates how travel restrictions, lockdowns and changing health care regulations disproportionately affected patients seeking fertility treatment outside their home countries.

Czechia has become an important destination for cross-border reproductive care, attracting patients from countries where fertility treatment may be more expensive, legally restricted or less accessible.

However, the pandemic exposed the fragility of relying on international travel to access essential reproductive health care.

The study also revealed significant differences in demand depending on patients' countries of origin.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.